Sponsor Check › Person
Related person on Form D filings · address state as listed: CA · listed Jul 31, 2009 → Jun 10, 2019
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
No SEC search has run yet for this person.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
0 of 23 offerings report sales commissions; 1 reports finder's fees totalling $625,000; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Feb 7, 2023 D/A File 021-466418 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing |
| EDGAR ↗ | Jun 10, 2019 D/A File 021-334548 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 19, 2018 D File 021-328429 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Oct 11, 2016 D File 021-272172 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 13, 2016 D File 021-255057 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 16, 2015 D File 021-243920 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 5, 2015 D File 021-235286 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 27, 2015 D File 021-232974 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 14, 2014 D File 021-226318 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 1, 2014 D File 021-225593 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 21, 2013 D File 021-201650 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 3, 2013 D File 021-189403 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 7, 2012 D File 021-179390 | $0 | $625,000 (est.) | $0 The proceeds will be used for general corporate purposes. | None listed on this filing |
| EDGAR ↗ | May 23, 2012 D File 021-178674 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 17, 2012 D File 021-171983 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 13, 2011 D File 021-162776 | $0 | $0 | $0 Proceeds will be used for the ARX-01 Phase 3 clinical trial in addition to the general business purposes. | None listed on this filing |
| EDGAR ↗ | Feb 7, 2011 D/A File 021-152596 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 3, 2011 D File 021-152839 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 21, 2010 D File 021-147977 | $0 | $0 | $0 The proceeds will be used for general corporate purposes. | None listed on this filing |
| EDGAR ↗ | Jul 13, 2010 D File 021-144847 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 29, 2009 D File 021-44118 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 25, 2009 D File 021-115115 | $0 | $0 | $0 The proceeds will be used for general corporate purposes. | None listed on this filing |
| EDGAR ↗ | Jul 31, 2009 D File 021-98423 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Spiral Therapeutics Inc group: Spiral | Director | Feb 7, 2023 | D/A | $10,904,985 similar: $829,831–$9,999,998 | $10,904,985 | 48 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Spiral Therapeutics Inc group: Spiral | Director | Dec 2, 2022 | D | $8,245,175 similar: $829,831–$9,999,998 | $1,265,343 | 12 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | USGI MEDICAL INC | Director | Jun 10, 2019 | D/A | $4,000,000 similar: $829,831–$9,999,998 | $2,400,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | USGI MEDICAL INC | Director | Mar 11, 2019 | D | $2,000,000 similar: $829,831–$9,999,998 | $1,500,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Spiral Therapeutics Inc group: Spiral | Director | Dec 19, 2018 | D | $12,944,560 similar: $829,831–$9,999,998 | $8,474,654 | 38 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Vertiflex, Inc. | Director | Oct 11, 2016 | D | $15,148,999 similar: $829,831–$9,999,998 | $15,148,999 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Vertiflex, Inc. | Director | Jan 13, 2016 | D | $45,720,683 similar: $829,831–$9,999,998 | $26,825,680 | 8 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Vertiflex, Inc. | Director | Jul 16, 2015 | D | $5,000,000 similar: $1,100,015–$10,001,163 | $4,798,160 | 7 similar: 2–14 | $1 similar: $5,000–$50,000 |
| EDGAR ↗ | Carbylan Therapeutics, Inc. | Director | Mar 5, 2015 | D | $4,000,000 similar: $829,831–$9,999,998 | $4,000,000 | 4 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | USGI MEDICAL INC | Director | Jan 27, 2015 | D | $15,000,003 similar: $829,831–$9,999,998 | $15,000,003 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Carbylan Therapeutics, Inc. | Director | Oct 14, 2014 | D | $5,000,000 similar: $829,831–$9,999,998 | $5,000,000 | 4 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Vertiflex, Inc. | Director | Oct 1, 2014 | D | $6,000,000 similar: $500,000–$7,000,000 | $6,000,000 | 7 similar: 2–14 | $1 similar: $5,000–$50,000 |
| EDGAR ↗ | Vertiflex, Inc. | Director | Aug 21, 2013 | D | $4,000,000 | $4,000,000 | 7 | $1 |
| EDGAR ↗ | Carbylan Therapeutics, Inc. | Director | Jan 3, 2013 | D | $13,228,600 | $5,999,999 | 4 | No minimum reported |
| EDGAR ↗ | TALPHERA, INC. | Director | Jun 7, 2012 | D | $10,000,002 | $10,000,002 | 10 | No minimum reported |
| EDGAR ↗ | USGI MEDICAL INC | Director | May 23, 2012 | D | $17,046,059 | $16,548,170 | 8 | No minimum reported |
| EDGAR ↗ | Vertiflex, Inc. | Director | Jan 17, 2012 | D | $8,000,000 | $8,000,000 | 8 | $1 |
| EDGAR ↗ | TALPHERA, INC. | Director | Jul 13, 2011 | D | $20,839,994 | $20,839,994 | 2 | No minimum reported |
| EDGAR ↗ | Vertiflex, Inc. | Director | Feb 7, 2011 | D/A | $14,600,000 | $14,000,000 | 8 | $1 |
| EDGAR ↗ | Vertiflex, Inc. | Director | Feb 4, 2011 | D/A | $14,600,000 | $14,000,000 | 8 | $1 |
| EDGAR ↗ | PneumRx Inc | Director | Jan 3, 2011 | D | $20,472,850 | $11,878,824 | 30 | No minimum reported |
| EDGAR ↗ | Vertiflex, Inc. | Director | Dec 28, 2010 | D | $12,000,000 | $8,400,000 | 5 | $1 |
| EDGAR ↗ | TALPHERA, INC. | Director | Sep 21, 2010 | D | $12,001,200 | $8,000,800 | 8 | No minimum reported |
| EDGAR ↗ | Vertiflex, Inc. | Director | Jul 13, 2010 | D | $2,000,200 | $2,000,000 | 5 | No minimum reported |
| EDGAR ↗ | COAPT SYSTEMS INC | Director | Dec 29, 2009 | D | $8,999,860 | $3,726,866 | 51 | $1 |
| EDGAR ↗ | TALPHERA, INC. | Director | Nov 25, 2009 | D | $30,000,000 | $14,814,106 | 8 | No minimum reported |
| EDGAR ↗ | Vertiflex, Inc. | Director | Jul 31, 2009 | D | $8,000,000 | $8,000,000 | 5 | $1 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Other Technology / 506(b) (17,390 filings); Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Guy Nohra. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Guy Nohra appears on a new Form D, or when a court case or SEC action is matched to them. See plans →